Novo Nordisk has announced the appointment of Maziar Mike Doustdar as its new president and chief executive officer (CEO).
Doustdar, who will assume the role on 7 August, has been serving as Novo’s executive vice president of international operations for the past decade.
He originally joined the company in 1992 and held a range of positions across finance, IT, logistics, operations and marketing, before being promoted to general manager of Novo Nordisk Near East.
Doustdar subsequently held roles of increasing responsibility at the company, including vice president of business area Near East, head of business area Oceania South East Asia, and senior vice president of international operations.
He also currently serves as a member of Orion Corporation’s board of directors.
Doustdar said: “It’s an enormous privilege to lead this company at a time of tremendous opportunity and change… From my decades in leadership roles across Novo Nordisk, I know the extraordinary talent and commitment of our people and the excellence of our science.”
Novo Nordisk Chair, Helge Lund, added: “Mike is an exceptional leader and has the unanimous support of the board. We are confident that he is the best person to lead Novo Nordisk through its next growth phase.”
Doustdar’s appointment follows a “comprehensive process” that included external and internal candidates, Novo outlined. He succeeds Lars Fruergaard Jørgensen.